Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

60 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Progression to insulin therapy among patients with type 2 diabetes treated with sitagliptin or sulphonylurea plus metformin dual therapy.
Inzucchi SE, Tunceli K, Qiu Y, Rajpathak S, Brodovicz KG, Engel SS, Mavros P, Radican L, Brudi P, Li Z, Fan CP, Hanna B, Tang J, Blonde L. Inzucchi SE, et al. Among authors: brudi p. Diabetes Obes Metab. 2015 Oct;17(10):956-64. doi: 10.1111/dom.12489. Epub 2015 Jun 22. Diabetes Obes Metab. 2015. PMID: 25962401 Free PMC article.
Body mass index impacts the choice of lipid-lowering treatment with no correlation to blood cholesterol - Findings from 52 916 patients in the Dyslipidemia International Study (DYSIS).
Ferrières J, Lautsch D, Gitt AK, De Ferrari G, Toplak H, Elisaf M, Drexel H, Horack M, Baxter C, Ambegaonkar B, Brudi P, Toth PP. Ferrières J, et al. Among authors: brudi p. Diabetes Obes Metab. 2018 Nov;20(11):2670-2674. doi: 10.1111/dom.13415. Epub 2018 Jul 10. Diabetes Obes Metab. 2018. PMID: 29888459 Free PMC article.
Lipid-altering efficacy and safety profile of combination therapy with ezetimibe/statin vs. statin monotherapy in patients with and without diabetes: an analysis of pooled data from 27 clinical trials.
Leiter LA, Betteridge DJ, Farnier M, Guyton JR, Lin J, Shah A, Johnson-Levonas AO, Brudi P. Leiter LA, et al. Among authors: brudi p. Diabetes Obes Metab. 2011 Jul;13(7):615-28. doi: 10.1111/j.1463-1326.2011.01383.x. Diabetes Obes Metab. 2011. PMID: 21332628
Effects of extended-release niacin/laropiprant on correlations between apolipoprotein B, LDL-cholesterol and non-HDL-cholesterol in patients with type 2 diabetes.
Brinton EA, Triscari J, Brudi P, Chen E, Johnson-Levonas AO, Sisk CM, Ruck RA, MacLean AA, Maccubbin D, Mitchel YB. Brinton EA, et al. Among authors: brudi p. Lipids Health Dis. 2016 Jul 12;15(1):116. doi: 10.1186/s12944-016-0282-8. Lipids Health Dis. 2016. PMID: 27405296 Free PMC article. Clinical Trial.
Frequency and predictors of cholesterol target attainment in patients with stable coronary heart disease in Belgium: results from the Dyslipidemia International Study II (DYSIS II CHD).
Hermans MP, Gevaert S, Descamps O, Missault L, Gillot B, De Keyzer D, Lautsch D, Brudi P, Ambegaonkar B, Vyas A, Horack M, Gitt A. Hermans MP, et al. Among authors: brudi p. Acta Clin Belg. 2019 Dec;74(6):399-404. doi: 10.1080/17843286.2018.1539203. Epub 2018 Oct 25. Acta Clin Belg. 2019. PMID: 30355016
60 results